未找到相关数据
Long-term outcomes of chronic immune-related adverse events from adjuvant anti-PD-1 therapy for high-risk resected melanoma
被引：0
作者：
Goodman, Rachel S.
Lawless, Aleigha
Woodford, Rachel
Fa'ak, Faisal
Tipirneni, Asha
Patrinely, James Randall
Yeoh, Hui-Ling
Rapisuwon, Suthee
Haydon, Andrew
Osman, Iman
Mehnert, Janice M.
Long, Georgina V.
Sullivan, Ryan J.
Carlino, Matteo S.
Menzies, Alexander M.
Johnson, Douglas Buckner
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN USA
[2] Massachusetts Gen Hosp, Boston, MA USA
[3] Melanoma Inst Australia, Sydney, NSW, Australia
[4] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, Mineola, NY USA
[5] Georgetown Univ, Med Ctr, Washington, DC USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[7] Alfred Hlth, Melbourne, Vic, Australia
[8] Washington Canc Inst, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[9] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[10] NYU, Sch Med, New York, NY USA
[11] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[12] Royal North Shore & Mater Hosp, Sydney, NSW, Australia
[13] Westmead & Blacktown Hosp, Wentworthville, NSW, Australia
[14] Melanoma Inst Australia, Sydney, NSW, Australia
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9591
引用
收藏
页数：1
相关论文